1.
Kumar S, Mehta R, Sah R. Commentary on “Pembrolizumab in gestational trophoblastic neoplasia: systematic review and meta-analysis with sub-group analysis of potential prognostic factors. Clinics [Internet]. 2025 Jan. 27 [cited 2025 Nov. 9];80:100651. Available from: https://revistas.usp.br/clinics/article/view/240599